MLYS10:00 AMMineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)Presentation / Abstract • Phase 3Late-breaking poster presentation Sun, Jun 14, 2026, 10:00 AM EDTGmineralystx.com
MLYS4:05 PMMineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conferencemineralystx.com
MLYS7:00 AMMineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)Presentation / Abstract • Phase 3Late-breaking poster presentation Sun, Jun 14, 2026, 9:00 AM CTGmineralystx.com
MLYS6:05 AMMineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stockmineralystx.com
MLYS6:00 AMMineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financingmineralystx.com
MLYS11:15 AMMineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)Presentation / Abstract • Phase 3ESH 2026 presentation Sat, May 30, 2026, 11:15 AM EDTGmineralystx.com
MLYS8:00 AMMineralys Therapeutics to Participate in the Jefferies Global Healthcare Conferencemineralystx.com
MLYS4:05 PMMineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)Presentation / Abstract • Phase 3Oral presentation Sat, May 30, 2026, 5:15 PM CESTmineralystx.com
MLYS4:05 PMMineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updatemineralystx.com
MLYS5:34 PMMineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)mineralystx.com
MLYS8:00 AMMineralys Therapeutics to Participate in the Bank of America Securities Health Care Conferencemineralystx.com
MLYS4:05 PMMineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026mineralystx.com